Response to Jefford

J Natl Cancer Inst. 2020 Mar 1;112(3):322-323. doi: 10.1093/jnci/djz129.

Authors

Larissa Nekhlyudov¹, Lawrence N Shulman², Paul B Jacobsen³, Michelle A Mollica³, Ann M Geiger³, Deborah K Mayer^{4

5}

Affiliations

¹ Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
² Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
³ Healthcare Delivery Research Program, National Cancer Institute, Bethesda, MD.
⁴ UNC Lineberger Comprehensive Cancer Center and School of Nursing, University of North Carolina-Chapel Hill, NC.
⁵ Office of Cancer Survivorship, National Cancer Institute, Bethesda, MD.

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Neoplasms*
Research
Survivorship*